Concepedia

Louis Hollingsworth

LH

Statistics

Publications

9

Citations

1.7K

H-Index

9

Active since

2016

Affiliations

Harvard University(Current)

Boston Children's Hospital

Tri-Institutional PhD Program in Chemical Biology

Cornell University

Memorial Sloan Kettering Cancer Center

Louis Hollingsworth is an author at Harvard University specializing in life sciences, molecular biology, and inflammation.

ORCID

Publications per year

2016–2024

9

Publications

9

FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

Jun Hu, Xing Liu, Shiyu Xia et al. · Nature Immunology · 2020 · 1.1K citations · Full text

, , +5

DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation

Louis Hollingsworth, Humayun Sharif, Andrew R. Griswold et al. · Nature · 2021 · 199 citations · Full text

, , +13

NINJ1 mediates plasma membrane rupture by cutting and releasing membrane disks

Liron David, Jazlyn P. Borges, Louis Hollingsworth et al. · Cell · 2024 · 136 citations · Full text

, , +7

Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment

Humayun Sharif, Louis Hollingsworth, Andrew R. Griswold et al. · Immunity · 2021 · 92 citations · Full text

, , +10

Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes

Louis Hollingsworth, Liron David, Yang Li et al. · Nature Communications · 2021 · 85 citations · Full text

, , +14

1–5 of 9